Texas Institute for Neuroogical Disorders-Sherman-Site Number:8400151 — Sherman, Texas

Texas Institute for Neuroogical Disorders-Sherman-Site Number:8400151 is a clinical research site located in Sherman, Texas, United States 75092.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Institute for Neuroogical Disorders-Sherman-Site Number:8400151 has participated in 1 clinical trials.

Therapeutic areas: Relapsing Multiple Sclerosis.

Sponsors: Sanofi.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Sherman

Browse all research sites in Texas · View every site in Sherman

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Institute for Neuroogical Disorders-Sherman-Site Number:8400151?

Texas Institute for Neuroogical Disorders-Sherman-Site Number:8400151 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Institute for Neuroogical Disorders-Sherman-Site Number:8400151 conducted?

Texas Institute for Neuroogical Disorders-Sherman-Site Number:8400151 has 1 clinical trials on record. Their work covers Relapsing Multiple Sclerosis.

Is Texas Institute for Neuroogical Disorders-Sherman-Site Number:8400151 accredited by Crixeo Clinical Trials?

Texas Institute for Neuroogical Disorders-Sherman-Site Number:8400151 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Institute for Neuroogical Disorders-Sherman-Site Number:8400151?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.